Business report

B2B/B2B2C competitive environment, supply and demand pain points, strategies and use cases

company logo

Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) — The “Growth Opportunities of Commercial In Vitro Diagnostic Models” report has been added to from ResearchAndMarkets.com offer.

This study assesses the business potential of e-commerce across industries, creating resilient healthcare and diagnostics market opportunities for R&D, manufacturing, and supply chain functions. It explores other scalable and profitable business opportunities with new B2B products, custom outsourcing services, and technology tools for efficiency and ease of operations.

The IVD market is buoyant due to the growing demand for products, molecular diagnostics, immunoassays and POCT in chronic diseases. Rising consumerization, telehealth and e-pharmacy are also pushing it towards greater digitization with advanced artificial intelligence, machine learning and Internet of Things technologies.

The study also examines the competitive environment, strategies, market patterns and use cases for success in the IVD E-commerce Platform industry.

Market overview

Diagnostics are at the heart of healthcare, but not accessible to everyone. A 2020 Lancet study indicates that 47% of the world’s population has little or no access to accurate diagnostics, underscoring the need for equitable distribution across geographies and containing supply costs.

The COVID-19 pandemic has increased the demand for personal protective equipment, molecular diagnostic consumables, vaccines and POCT tests for SARS-Cov2. However, severe supply and logistical issues due to poor sourcing strategies have led to manufacturing delays and increased diagnostics and healthcare costs. Providers of R&D prototyping, small-batch manufacturing services and niche test labs saw the biggest drop in revenue across the value chain.

The coronavirus has also accelerated the digitization of healthcare, including in vitro diagnostics (IVD). Engineering and technological innovations provide opportunities to create new e-commerce platform solutions in the diagnostics segment, emphasizing global connectivity, transparency, access, scalability and cost-effectiveness . These features reduce gaps in the IVD industry, improve access, and democratize diagnostics to empower providers, payers, and patients.

Lessons learned from the pandemic in 2020 and 2021 serve as building blocks to strengthen health systems, mainly the delivery of timely health services, attention to health personnel, the need for information systems robust health, access to diagnostics (analogs to essential drugs), efficient supply and supply chain, as well as transparent communication and interconnection, funding, leadership and governance.

E-commerce marketplaces for healthcare and IVDs provide the ability to buy, sell, rent, market, and obtain diagnostic products and service information on any internet-enabled device, such as desktop (web-based) or mobile (mCommerce). Pharmaceutical companies, biotechnology companies, contract research organizations, hospitals, clinics, universities, laboratories, government and customers can use these technology platforms to access the global ecosystem. As the e-commerce technology infrastructure evolves, critical technologies enabling healthcare transactions include EDI, barcodes, cloud, product data interchange, and electronic forms.

Main topics covered:

1. Strategic imperatives

  • Why is it increasingly difficult to grow taller?

  • The strategic imperative

  • The Impact of Top 3 Strategic Imperatives on the In Vitro Diagnostics E-Business Platform Industry

  • Growth opportunities fuel the growth pipeline engine

2. Analysis of growth opportunities

3. Macro to Micro In Vitro Diagnostics eCommerce Business Model

  • Macro-to-micro vision

  • Technology adoption among patients, providers, and physicians

  • Cross-industry collaborations encourage industry players to explore potential partnership opportunities

  • Cross-industry interconnection acts as a force multiplier for B2B and B2C markets

4. Supply Chain Participants and Use

  • Preferred channels and strategic priorities

  • Preferred channel by type of diagnostic device

  • Preferred channel by solutions and service types

  • Market attractiveness and partnership opportunity

5. IVD B2B, B2B2C eCommerce – Competitive Environment, Supply and Demand Pain Points, Strategies and Use Cases

  • Competitive environment – IVD and e-commerce market

  • B2B e-commerce supply and demand channel pain points

  • IVD E-Commerce Industry Participant Strategies

  • Benefits of B2B Supply Chain Market for Retail Value Chain Stakeholders

  • Use Cases – Abbott Diagnostics

  • Use Cases – Siemens Healthineers

  • Use Cases – Thermo Fisher Scientific Corporation

  • Use Case – LabX

  • Use Case – KWIPPED

6. Provision of R&D and use cases

7. B2C Digital/ePharmacy Use Case – Wazoku – Competitive Environment, Weaknesses, Strategies and Use Cases

  • Competitive environment – B2C Digital/ePharmacy

  • Weaknesses of B2C Digital/ePharmacy Vendors and Vendors

  • B2C Digital/ePharmacy Industry Participant Strategies

  • B2C Digital/ePharmacy offers value-added customer-centric services and products

  • Use Case – Amazon Pharmacy

  • Use Case – CVS Pharmacy

  • Case Study – Walgreens Boots Alliance

  • Conclusion

8. Universe of growth opportunities

  • Growth Opportunity 1 – Technology-enabled e-commerce supply chain for improved and scalable customer experience

  • Growth Opportunity 2 – R&D e-commerce market unlocks opportunities and optimizes cost and time for researchers and scientists

  • Growth Opportunity 3 – Telepharmacy Services for Comprehensive Disease Management

9. Appendix

Companies cited

For more information on this report, visit https://www.researchandmarkets.com/r/aiybjd

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900